Skip Navigation


European Heart Journal Advance Access originally published online on March 30, 2005
European Heart Journal 2005 26(11):1052-1053; doi:10.1093/eurheartj/ehi244
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/11/1052    most recent
ehi244v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Crook, D.
Right arrow Articles by Smith, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crook, D.
Right arrow Articles by Smith, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Brain natriuretic peptide in heart failure: an improving prognosis?

David Crook and Helen Smith*

Division of Primary Care and Public Health, Brighton and Sussex Medical School, Mayfield House, Falmer, Brighton BN1 9PH, UK

* Corresponding author. Tel: +44 1273 644192; fax: +44 1273 644440. E-mail address: h.e.smith@bsms.ac.uk

This editorial refers to ‘Using BNP to develop a risk score for heart failure in primary care’{dagger} by D. Adlam et al., on page 1086

The first 10% of the full text of this article appears below.

Over the last half century heart disease has undergone a dramatic and technology-driven transformation, from a condition that typically manifested itself as an acute and often fatal episode into a disease that in many cases is becoming survivable. The downside of this inexorable march towards progress is that although overall mortality from heart disease is falling, the prevalence of conditions such as heart failure (HF) is increasing. In Europe alone there are an estimated 10 million patients with HF.1 Being the final common pathway for many types of heart disease, HF has a poor prognosis and re-lapse . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Using BNP to develop a risk score for heart failure in primary care
David Adlam, Paul Silcocks, and Nigel Sparrow
EHJ 2005 26: 1086-1093. [Abstract] [FREE Full Text]